Annah S. Rolig

1.6k total citations
23 papers, 1.2k citations indexed

About

Annah S. Rolig is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Annah S. Rolig has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Annah S. Rolig's work include Cancer Immunotherapy and Biomarkers (7 papers), Galectins and Cancer Biology (6 papers) and CAR-T cell therapy research (4 papers). Annah S. Rolig is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Galectins and Cancer Biology (6 papers) and CAR-T cell therapy research (4 papers). Annah S. Rolig collaborates with scholars based in United States, India and Canada. Annah S. Rolig's co-authors include William L. Redmond, Karen Guillemin, Mohammad Farhad, Adam R. Burns, Michael M. Tamkun, Kristen M.S. O’Connell, Karen M. Ottemann, Brendan J. M. Bohannan, R. Parthasarathy and Jennifer D. Whitesell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Annah S. Rolig

22 papers receiving 1.2k citations

Peers

Countries citing papers authored by Annah S. Rolig

Since Specialization

Citations

This map shows the geographic impact of Annah S. Rolig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annah S. Rolig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annah S. Rolig more than expected).

Fields of papers citing papers by Annah S. Rolig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annah S. Rolig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annah S. Rolig. The network helps show where Annah S. Rolig may publish in the future.

Co-authorship network of co-authors of Annah S. Rolig

This figure shows the co-authorship network connecting the top 25 collaborators of Annah S. Rolig. A scholar is included among the top collaborators of Annah S. Rolig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annah S. Rolig. Annah S. Rolig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The response to anti–PD-1 and anti–LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming 2025 ·Science Translational Medicine ·Annah S. Rolig, (unknown), (unknown), (unknown), Melissa J. Kasiewicz, (unknown), (unknown), William L. Miller, Yoshinobu Koguchi, Johanna K. Kaufmann, (unknown), (unknown), James Smothers, Matthew Adamow, (unknown), Ronglai Shen, Margaret K. Callahan, William L. Redmond	4
2	Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer 2025 ·Cancers ·Rama Rao Malla, (unknown), (unknown), (unknown), Vasudevaraju Padmaraju, (unknown), Annah S. Rolig, Sanjay V. Malhotra	3
3	INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), Melissa J. Kasiewicz, (unknown), Annah S. Rolig, (unknown), Bryan R. Becklund, (unknown), Yoshinobu Koguchi, Brendan P. Eckelman, (unknown), William L. Redmond	4
4	Mycobacterium w - a promising immunotherapeutic intervention for diseases 2024 ·Frontiers in Immunology ·(unknown), (unknown), Annah S. Rolig, Alexander Honkala, Dhanir Tailor, Lara E. Davis, Rajiv Modi, Manjul Joshipura, (unknown), Sanjay V. Malhotra	1
5	Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth 2021 ·Cancer Immunology Research ·Mark Badeaux, Annah S. Rolig, (unknown), (unknown), Melissa J. Kasiewicz, (unknown), Jason F. Wiggins, Alexander Muir, Mark R. Sullivan, (unknown), Christopher Daige, Matthew G. Vander Heiden, Venkatesh Rajamanickam, James E. Wooldridge, William L. Redmond, Scott W. Rowlinson	15
6	Enhancing the Generation of Eomeshi CD8+ T Cells Augments the Efficacy of OX40- and CTLA-4–Targeted Immunotherapy 2021 ·Cancer Immunology Research ·(unknown), Annah S. Rolig, William L. Redmond	14
7	Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity 2021 ·OncoImmunology ·(unknown), Annah S. Rolig, Stefanie N. Linch, (unknown), Melissa J. Kasiewicz, Zhaoyu Sun, Peter G. Traber, Harold Shlevin, William L. Redmond	34
8	NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8⁺ T cell responses capable of curing multi-focal cancer 2020 ·Journal for ImmunoTherapy of Cancer ·Joshua M. Walker, Annah S. Rolig, Deborah H. Charych, Ute Hoch, Melissa J. Kasiewicz, (unknown), Michael J. McNamara, (unknown), William L. Redmond	25
9	Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8+ T Cell Development 2020 ·The Journal of Immunology ·(unknown), Annah S. Rolig, William L. Redmond	9
10	A bacterial immunomodulatory protein with lipocalin-like domains facilitates host–bacteria mutualism in larval zebrafish 2018 ·eLife ·Annah S. Rolig, Emily Goers Sweeney, (unknown), (unknown), Arden Perkins, (unknown), M. Kristina Hamilton, Karen Guillemin	47
11	The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment 2018 ·OncoImmunology ·Mohammad Farhad, Annah S. Rolig, William L. Redmond	158
12	Interhost dispersal alters microbiome assembly and can overwhelm host innate immunity in an experimental zebrafish model 2017 ·Proceedings of the National Academy of Sciences ·Adam R. Burns, Elizabeth T. Miller, (unknown), Annah S. Rolig, Kathryn Milligan‐Myhre, Steve Seredick, Karen Guillemin, Brendan J. M. Bohannan	122
13	The enteric nervous system promotes intestinal health by constraining microbiota composition 2017 ·PLoS Biology ·Annah S. Rolig, Erika Mittge, Julia Ganz, (unknown), Ellie Melançon, Travis J. Wiles, (unknown), W. Zac Stephens, Judith S Eisen, Karen Guillemin	110
14	Individual Members of the Microbiota Disproportionately Modulate Host Innate Immune Responses 2015 ·Cell Host & Microbe ·Annah S. Rolig, R. Parthasarathy, Adam R. Burns, Brendan J. M. Bohannan, Karen Guillemin	113
15	Spatial and Temporal Features of the Growth of a Bacterial Species Colonizing the Zebrafish Gut 2014 ·mBio ·Matthew Jemielita, Michael J. Taormina, Adam R. Burns, (unknown), Annah S. Rolig, Karen Guillemin, R. Parthasarathy	90
16	The Degree of Helicobacter pylori-Triggered Inflammation Is Manipulated by Preinfection Host Microbiota 2013 ·Infection and Immunity ·Annah S. Rolig, (unknown), Ethan Ahler, (unknown), Karen M. Ottemann	68
17	Helicobacter pylori Requires TlpD-Driven Chemotaxis To Proliferate in the Antrum 2012 ·Infection and Immunity ·Annah S. Rolig, (unknown), (unknown), Karen M. Ottemann	52
18	Bacterial chemotaxis modulates host cell apoptosis to establish a T-helper cell, type 17 (Th17)-dominant immune response in Helicobacter pylori infection 2011 ·Proceedings of the National Academy of Sciences ·Annah S. Rolig, (unknown), Karen M. Ottemann	36
19	A cytoskeletal-based perimeter fence selectively corrals a sub-population of cell surface Kv2.1 channels 2007 ·Journal of Cell Science ·Michael M. Tamkun, Kristen M.S. O’Connell, Annah S. Rolig	77
20	Kv2.1 Potassium Channels Are Retained within Dynamic Cell Surface Microdomains That Are Defined by a Perimeter Fence 2006 ·Journal of Neuroscience ·Kristen M.S. O’Connell, Annah S. Rolig, Jennifer D. Whitesell, Michael M. Tamkun	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact